1.
Clin Case Rep
; 9(6): e04349, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34194811
RESUMO
Re-exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs.
